Sites
Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network
Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.
How Paper and Electronic Source Data Meet ALCOA-C Principles
ALCOA ensures source data is safe and effective, but how does it differ for data collected on paper vs. electronically?
Budget Negotiation 101
Clinical trial costs vary from each site, and a prolonged budget negotiation process can affect the startup timeline.
Strategies for Successful Site Selection in Clinical Trials
While clinical trial site selection aids in a trial’s success, it’s critical to maximize the study's time, resources, and funds.
Keys to Unblocking the Innovation Bottleneck in Research
As the clinical trial industry has evolved in the past decade, it’s invited more complexity into operations and workflows.
How the IND 30-day Hold Impacts Clinical Trial Activities
Find out what research activities can and cannot be conducted during the Investigational New Drug (IND) 30-day hold period.
Streamline Study Startup with Improved Site Selection & Feasibility
Identifying the best prepared and performing sites for a study is essential to success. Explore strategies to improve site selection and feasibility.
Scale Your Training Program: 3 Successful Models
Finding the best training solutions begins with understanding your organization’s training needs.
Beginner’s Guide to 21 CFR Part 11 Compliance
FDA released regulations in 1997 outlining how 21 CFR Part 11 applies to electronic records and electronic signatures in clinical research.
Regulatory and Ethical Considerations for eConsent in Research
If any part of your informed consent process involves an electronic component, you’re conducting eConsent.
Advarra Trend Report: Current State of Trial Opportunity and Selection
Insights into the site selection process and the information sites provide as part of site feasibility questionnaire completion.
Enhancing Research Conduct Using eConsent
The Belmont Report established informed consent parameters in 1976, but there are no federal regulations surrounding electronic consent.